Cargando…
The association between human papillomavirus and bladder cancer: Evidence from meta‐analysis and two‐sample mendelian randomization
INTRODUCTION: Bladder cancer (BCa) is the 10th most common type of cancer worldwide, and human papillomavirus (HPV) is the most common sexually transmitted infection. However, the relationship between HPV infection and the risk of BCa is still controversial and inconclusive. METHODS: This systematic...
Autores principales: | Sun, Jian‐Xuan, Xu, Jin‐Zhou, Liu, Chen‐Qian, An, Ye, Xu, Meng‐Yao, Zhong, Xing‐Yu, Zeng, Na, Ma, Si‐Yang, He, Hao‐Dong, Hu, Jia, Liu, Zheng, Wang, Shao‐Gang, Xia, Qi‐Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092419/ https://www.ncbi.nlm.nih.gov/pubmed/36226344 http://dx.doi.org/10.1002/jmv.28208 |
Ejemplares similares
-
The effect of different timing of blood transfusion on oncological outcomes of patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis
por: Ma, Si-Yang, et al.
Publicado: (2023) -
Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette–Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis
por: Zeng, Na, et al.
Publicado: (2023) -
A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer
por: Sun, Jian-Xuan, et al.
Publicado: (2022) -
Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intravesical BCG instillation
por: Sun, Jian-Xuan, et al.
Publicado: (2023) -
Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer
por: An, Ye, et al.
Publicado: (2022)